The company had, through its letter dated 31st March, 2021, made a disclosure regarding the acquisition of 100% stake in Hemmo Pharmaceuticals (‘Hemmo’), for an aggregate cash consideration of Rs 775 crores and earn-outs linked to achievement of milestones, by Piramal Pharma (‘PPL’), subsidiary of the Company (‘Transaction’). Piramal Enterprises has informed that PPL has completed the acquisition of Hemmo on 22nd June, 2021 and the Transaction is now closed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Bajaj Finance | 955.05 |
| Shriram Finance | 1007.95 |
| Aditya Birla Capital | 363.05 |
| Chola Invest & Fin. | 1676.05 |
| Tata Capital | 321.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: